TY - JOUR
T1 - The cannabinoid receptor 2 is critical for the host response to sepsis
AU - Tschöp, Johannes
AU - Kasten, Kevin R.
AU - Nogueiras, Ruben
AU - Goetzman, Holly S.
AU - Cave, Cynthia M.
AU - England, Lisa G.
AU - Dattilo, Jonathan
AU - Lentsch, Alex B.
AU - Tschöp, Matthias H.
AU - Caldwell, Charles C.
PY - 2009/7/1
Y1 - 2009/7/1
N2 - Leukocyte function can be modulated through the cannabinoid receptor 2 (CB2R). Using a cecal ligation and puncture (CLP) model of sepsis, we examined the role of the CB2R during the immune response to an overwhelming infection. CB2R-knock out (KO) mice showed decreased survival as compared with wild-type mice. CB2R-KO mice also had increased serum IL-6 and bacteremia. Twenty-four hours after CLP, the CB2R-deficient mice had increased lung injury. Additionally, CB2R-deficiency led to increased neutrophil recruitment, decreased neutrophil activation, and decreased p38 activity at the site of infection. Consistent with a novel role for CB2R in sepsis, CB2R-agonist treatment in wild-type mice increased the mean survival time in response to CLP. Treatment with CB2R-agonist also decreased serum IL-6 levels, bacteremia, and damage to the lungs compared with vehicle-treated mice. Finally, the CB2R agonist decreased neutrophil recruitment, while increasing neutrophil activation and p38 activity at the site of infection compared with vehicle-treated mice. These data suggest that CB2R is a critical regulator of the immune response to sepsis and may be a novel therapeutic target.
AB - Leukocyte function can be modulated through the cannabinoid receptor 2 (CB2R). Using a cecal ligation and puncture (CLP) model of sepsis, we examined the role of the CB2R during the immune response to an overwhelming infection. CB2R-knock out (KO) mice showed decreased survival as compared with wild-type mice. CB2R-KO mice also had increased serum IL-6 and bacteremia. Twenty-four hours after CLP, the CB2R-deficient mice had increased lung injury. Additionally, CB2R-deficiency led to increased neutrophil recruitment, decreased neutrophil activation, and decreased p38 activity at the site of infection. Consistent with a novel role for CB2R in sepsis, CB2R-agonist treatment in wild-type mice increased the mean survival time in response to CLP. Treatment with CB2R-agonist also decreased serum IL-6 levels, bacteremia, and damage to the lungs compared with vehicle-treated mice. Finally, the CB2R agonist decreased neutrophil recruitment, while increasing neutrophil activation and p38 activity at the site of infection compared with vehicle-treated mice. These data suggest that CB2R is a critical regulator of the immune response to sepsis and may be a novel therapeutic target.
UR - http://www.scopus.com/inward/record.url?scp=68949083424&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.0900203
DO - 10.4049/jimmunol.0900203
M3 - Article
C2 - 19525393
AN - SCOPUS:68949083424
SN - 0022-1767
VL - 183
SP - 499
EP - 505
JO - Journal of Immunology
JF - Journal of Immunology
IS - 1
ER -